Institutional Ownership
Elite Pharmaceuticals Inc Com
CUSIP 28659T200Common StockELTPQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
24.2%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Sep 1, 2020
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Sep 1, 2020 | Hakim Nasrat A | 13D/A | 24.2% | 267.27M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Kelleher Financial Advisors | 500 | $180 |